ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Operating margin 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) operating margin by fiscal year — reported operating income divided by reported revenue.
11.9%FY2025 · since FY2016: -51627.1% → 11.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 11.9% | +16938.9 pp |
| FY2024 | -16927.1% | -16841.9 pp |
| FY2023 | -85.2% | -11.8 pp |
| FY2022 | -73.4% | +34.4 pp |
| FY2021 | -107.8% | -1.9 pp |
| FY2020 | -105.9% | -142.1 pp |
| FY2019 | 36.3% | +382.8 pp |
| FY2018 | -346.5% | -228.7 pp |
| FY2017 | -117.8% | +51509.3 pp |
| FY2016 | -51627.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ARWR financial trends
ARWR RevenueARWR Net incomeARWR Net marginARWR Gross profitARWR Gross marginARWR Operating incomeARWR Operating cash flowARWR Free cash flowARWR Capital expendituresARWR Return on equityARWR Stock buybacksARWR Dividends paidARWR Total assetsARWR Total liabilitiesARWR Shareholders’ equityARWR overview →